Journal Mobile Options
Table of Contents
Vol. 217, No. 1, 2008
Issue release date: June 2008
Dermatology 2008;217:89–93

Clinical and Epidemiological Study of Cutaneous Tuberculosis in Northern Ethiopia

Terranova M. · Padovese V. · Fornari U. · Morrone A.
aItalian Dermatological Centre, Ayder Hospital, Mekele, Ethiopia; bSan Gallicano Institute, Preventive Medicine of Migration, Tourism and Tropical Dermatology, Rome, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Tuberculosis is a major public health problem in Ethiopia but cutaneous tuberculosis (CT) has not been documented. Objective: This study was conducted to determine its existence and its clinical pattern in Tigray, a northern region of Ethiopia. Methods: We report 202 cases of CT who attended the Italian Dermatological Centre in the 34-month period between January 2005 and October 2007. The diagnosis was made on a clinical, cytological and histological basis. Results: Clinically, 143 cases of scrofuloderma, 22 of lupus vulgaris, 18 of gumma, 11 of lichen scrofulosorum, 6 of tuberculosis verrucosa cutis and 2 of erythema induratum of Bazin were observed in our department. All patients were aged between 18 months and 69 years, and 49 were paediatric cases. Forty-five were HIV positive. Conclusion: The number of CT cases observed in the period of 34 months indicates a high incidence of the disease in the region also in the paediatric age. CT is still underdiagnosed due to the low number of dermatologists as well as the poor life conditions of the population and the traditional belief in magic medicine. The current study may therefore provide some indication about the epidemiology of CT in Ethiopia.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bravo FG, Gotuzzo E: Cutaneous tuberculosis. Clin Dermatol 2007;25:173–180.
  2. Zouhair K, Akhdari N, Nejjam F, Ouzzani T, Lakhdar H: Cutaneous tuberculosis in Morocco. Int J Infect Dis 2007;11:209–212.
  3. Umapathy KC, Begum R, Ravichandran G, Rahman F, Paramasivan CN, Ramanathan VD: Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Trop Med Int Health 2006;11:1521–1528.
  6. Farina MC, Gegundez MI, Pique E, Esteban J, Martín L, Requena L, Barat A, Fernández Guerrero M: Cutaneous tuberculosis: a clinical, histopathologic and bacteriologic study. J Am Acad Dermatol 1995;33:433–440.
  7. Choudhury AM, Ara S: Cutaneous tuberculosis: a study of 400 cases. Bangladesh Med Res Counc Bull 2006;32:60–65.
  8. Hajlaoui K, Fazaa B, Zermani R, Zeglaoui F, El Fekib N, Ezzine N, Kharfi M, Ben Jilani S, Kamoun MR: Cutaneous tuberculosis: a review of 38 cases. Tunis Med 2006;84:537–541.

    External Resources

  9. Ho CK, Ho MH, Chong LY: Cutaneous tuberculosis in Hong Kong: an update. Hong Kong Med J 2006;12:272–277.
  10. Vashisht P, Sahoo B, Khurana N, Reddy BS: Cutaneous tuberculosis in children and adolescents: a clinicohistological study. J Eur Acad Dermatol Venereol 2007;21:40–47.
  11. Sehgal VN, Srivastava G, Khurana VK, Sharma VK, Bhalla P, Beohar PC: An appraisal of epidemiologic, clinical, bacteriologic, histopathologic, and immunologic parameters in cutaneous tuberculosis. Int J Dermatol 1987;26:521–526.
  12. Kathuria P, Agarwal K, Koranne RV: The role of fine-needle aspiration cytology and Ziehl Neelsen staining in the diagnosis of cutaneous tuberculosis. Diagn Cytopathol 2006;4:826–829.

    External Resources

  13. Kumar B, Muralidhar S: Cutaneous tuberculosis: a twenty-year prospective study. Int J Tuberc Lung Dis 1999;3:494–500.
  14. Pandhi D, Reddy BSN, Chowdhary S, Khurana N: Cutaneous tuberculosis in Indian children: the importance of screening for involvement of internal organs. J Eur Acad Dermatol Venereol 2004;18:546–551.
  15. Aginam O: Beyond shamanism: the relevance of African traditional medicine in global health policy. Med Law 2007;26:191–201.

    External Resources

  16. Abate G: Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Ethiop Med J 2002;40:79–86.
  17. Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S, Hoffner S, Lindquist L: Molecular epidemiology and drug resistance of Mycobacteriumtuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002;40:1636–1643.
  18. Demissie M, Lemma E, Gebeyehu M, Lindtjorn B: Sensitivity to anti-tuberculosis drugs in HIV-positive and -negative patients in Addis Ababa. Scand J Infect Dis 2001;33:914–919.
  19. Yassin MA, Takele L, Gebresenbet S, Girma E, Lera M, Lendebo E, Cuevas LE: HIV and tuberculosis coinfection in the southern region of Ethiopia: a prospective epidemiological study. Scand J Infect Dis 2004;36:670–673.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50